---
title: Clobetasol + Gentamicin + Terbinafine + Zinc Sulphate Monohydrate
description: >-
  This combination medication is a topical treatment for inflammatory skin
  conditions complicated by bacterial and fungal infections. It is effective
  against dermatophytes, gram-negative bacteria and certain gram-positive
  bacteria.  This combined therapy addresses infections caused by multiple
  type...
is_banned: false
lastModified: '2025-09-22T17:22:08.844Z'
---
## **Usage**

This combination medication is a topical treatment for inflammatory skin conditions complicated by bacterial and fungal infections. It is effective against dermatophytes, gram-negative bacteria and certain gram-positive bacteria.  This combined therapy addresses infections caused by multiple types of pathogens as well as inflammation.

**Pharmacological Classification:**

* **Clobetasol:** Corticosteroid (high potency)
* **Gentamicin:** Aminoglycoside antibiotic
* **Terbinafine:** Allylamine antifungal
* **Zinc Sulphate Monohydrate:** Astringent

**Mechanism of Action:**

* **Clobetasol:** Suppresses the immune response, reducing inflammation and itching.
* **Gentamicin:** Inhibits bacterial protein synthesis.
* **Terbinafine:** Inhibits squalene epoxidase in fungal cells, disrupting cell wall formation.
* **Zinc Sulphate Monohydrate:** Provides astringent and antiseptic action.


## **Alternate Names**

No widely recognized alternate names exist for this four-drug combination.  Brand names may vary depending on the manufacturer (e.g., Clofin GT Ointment).


## **How It Works**

**Pharmacodynamics:**  The combined effect of the ingredients tackles fungal and bacterial infections while mitigating inflammation and promoting healing.

**Pharmacokinetics:** Primarily topical action. Systemic absorption of clobetasol can occur, especially with prolonged use or application over large areas. Gentamicin and zinc sulfate have limited systemic absorption when applied topically.  Terbinafine's absorption through the skin depends on the dose and the condition of the skin. It is metabolized in the liver and excreted in the urine.

**Mode of Action:**

* **Clobetasol:** Binds to glucocorticoid receptors, modulating gene expression and reducing inflammatory mediators.
* **Gentamicin:** Interferes with bacterial ribosomal function, inhibiting protein synthesis.
* **Terbinafine:** Inhibits squalene epoxidase, a key enzyme in fungal ergosterol biosynthesis.
* **Zinc Sulphate Monohydrate:** Exerts astringent effects through protein precipitation.

**Elimination Pathways:** Primarily renal excretion for systemically absorbed components (Clobetasol and Gentamicin). Hepatic metabolism followed by biliary/renal excretion for Terbinafine.



## **Dosage**

### **Standard Dosage**

#### **Adults:**  Apply a thin film to the affected skin area twice daily. Avoid prolonged use (generally not exceeding two weeks) and limit the amount used (e.g., no more than 50 grams per week unless directed by a physician).  The affected area should be clean and dry before application.

#### **Children:** Use in children under 12 is generally not recommended due to the high potency of clobetasol. If deemed necessary by a pediatrician, use should be restricted to small areas for short periods under strict medical supervision.

#### **Special Cases:**

* **Elderly Patients:** Use with caution due to increased risk of skin thinning and systemic absorption. Short-term use on small areas is recommended.
* **Patients with Renal Impairment:** Topical gentamicin absorption is minimal, so dosage adjustments are generally unnecessary. Caution advised in severe renal dysfunction.
* **Patients with Hepatic Dysfunction:**  Systemic absorption of topical agents is minimal, and hepatic involvement is not a primary concern with short-term topical use. Monitor for systemic side effects of Terbinafine in patients with liver disease, although they are unlikely from topical use.
* **Patients with Comorbid Conditions:**  Caution in patients with diabetes (monitor blood glucose), as clobetasol can affect glucose control.


### **Clinical Use Cases**

This combination is not typically used in clinical settings like intubation, surgical procedures, mechanical ventilation, or ICU/emergency situations. It is intended for topical dermatological use only.


### **Dosage Adjustments**

Always individualize dosage based on the patient's condition, the severity of the infection, and response to treatment.  Consider renal/hepatic function and other medical conditions when adjusting doses.


## **Side Effects**


### **Common Side Effects**

Itching, irritation, burning, stinging, dry skin, skin peeling, redness at application site.


### **Rare but Serious Side Effects**

Skin atrophy, telangiectasia, hypopigmentation, hypertrichosis, allergic contact dermatitis, folliculitis, secondary infection, glaucoma (if applied near eyes), systemic effects of corticosteroids (with prolonged or extensive use).


### **Long-Term Effects**

Skin thinning, striae, Cushing's syndrome (with extensive or prolonged use), glaucoma.


### **Adverse Drug Reactions (ADR)**

Severe allergic reactions, adrenal suppression.



## **Contraindications**

Hypersensitivity to any component, rosacea, acne vulgaris, perioral dermatitis, primary viral skin infections (herpes, chickenpox, shingles), untreated bacterial/fungal skin infections.

## **Drug Interactions**

No significant drug interactions are expected with topical application. Systemic interactions may occur with other CYP3A4 substrates, inhibitors and inducers when Clobetasol is systemically absorbed.


## **Pregnancy and Breastfeeding**

**Pregnancy:** Clobetasol is a Category C drug. Use only if potential benefit justifies the risk to the fetus. Avoid applying to large areas or for prolonged periods.

**Breastfeeding:**  Limited data. Caution advised; avoid applying to areas that may come into contact with the infant. Terbinafine can be present in breast milk, Clobetasol is potentially hazardous, Gentamicin and Zinc sulfate monohydrate's data are not available about lactation.


## **Drug Profile Summary**

(See previous sections for details)


## **Popular Combinations**

This formulation itself is a combination product. Adding other antifungals or corticosteroids, depending on the specific infection.


## **Precautions**

(See previous sections for detailed information)


## **FAQs (Frequently Asked Questions)**

**Q1: What is the recommended dosage for Clobetasol + Gentamicin + Terbinafine + Zinc Sulphate Monohydrate?**

**A:** Apply a thin film to the affected area twice daily.  Do not exceed two weeks of continuous use. Limit application to 50 grams/week.

**Q2:  Can this combination be used on the face?**

**A:**  Use with extreme caution on the face; avoid prolonged use due to the risk of skin atrophy and perioral dermatitis.

**Q3: What are the signs of an allergic reaction to this medication?**

**A:** Hives, difficulty breathing, swelling of the face, lips, tongue, or throat.

**Q4: Can I use this ointment if I am pregnant or breastfeeding?**

**A:** Consult a doctor. It's generally not recommended unless the benefits outweigh the potential risks.

**Q5:  Can this cream be used to treat acne?**

**A:**  No, it is not recommended for acne and may worsen the condition.

**Q6: What should I do if my condition does not improve after using this medication?**

**A:** Consult a physician. It's possible a different treatment may be necessary.

**Q7: Can I cover the treated area with a bandage?**

**A:**  Generally, avoid using occlusive dressings unless directed by a doctor.

**Q8: What should I do if I accidentally get this medication in my eyes?**

**A:** Rinse thoroughly with water and consult a physician if irritation persists.

**Q9: Can I use this cream on broken or damaged skin?**

**A:** Consult a doctor first. Application to broken skin can increase systemic absorption of the medication.

**Q10: What are the long-term effects of using this combination frequently?**

**A:**  Skin thinning, stretch marks, and changes in skin pigmentation can occur with prolonged use.

